4-(6-Chloro-1H-benzo[d]imidazol-2-yl)phenol

Catalog No.: 
ACLEMT972
CAS No.: 
113561-60-7
Molecular Formula: 
C13H9ClN2O
Molecular Weight: 
244.68
4-(6-Chloro-1H-benzo[d]imidazol-2-yl)phenol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$215.00InquiryInquiry
250mg98%$366.00InquiryInquiry
1g98%$992.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(6-Chloro-1H-benzo[d]imidazol-2-yl)phenol
IUPAC Name4-(6-chloro-1H-benzo[d]imidazol-2-yl)phenol
MDL No.MFCD00220106
Molecular FormulaC13H9ClN2O
Molecular Weight244.68
SMILESOC1=CC=C(C2=NC3=CC=C(Cl)C=C3N2)C=C1
InChI KeyGGUHTGJGVJGBEI-UHFFFAOYSA-N
Synonym4-(5-chloro-1H-benzo[d]imidazol-2-yl)phenol;Phenol, 4-(6-chloro-1H-benzimidazol-2-yl)-;4-(5-CHLORO-1H-1,3-BENZODIAZOL-2-YL)PHENOL;4-(6-Chloro-1H-benzo[d]imidazol-2-yl)phenol
CAS No.113561-60-7
PubChem CID1211924

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACLEMT972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTFAC487 route compound structure diagram
    ACTFAC48795-83-0In Stock
  2. Plus
  3. ACONBM672 route compound structure diagram
    ACONBM672114-63-6In Stock
  4. Then
  5. ACLEMT972 route product structure diagram
    ACLEMT972113561-60-7
Inquiry

2. ACLEMT972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLEMT972 route product structure diagram
    ACLEMT972113561-60-7
Inquiry

3. ACLEMT972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLEMT972 route product structure diagram
    ACLEMT972113561-60-7
Inquiry

Comments (0)